Meridian Wealth Partners’s TELA Bio TELA Stock Holding History

Meridian Wealth Partners’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-238	Closed	-$4K	–	1131
2021 Q1	$4K	Buy	+238	New	+$3.58K	﹤0.01%	798

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Meridian Wealth Partners's TELA Position: Q2 2021 in Review

Meridian Wealth Partners sold out of TELA Bio (TELA) in Q2 2021, closing a stake of 238 shares — an estimated $4K sold.

Meridian Wealth Partners first reported a position in TELA in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2021.

Meridian Wealth Partners reported no remaining TELA Bio position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 238 TELA Bio shares in Q2 2021, an estimated $4K.
Meridian Wealth Partners first reported a position in TELA Bio in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's TELA Bio position peaked at $4K in Q1 2021.
45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.